PLASMIDSYSTEM
European patent · EP3722434 · In force
Register entry
- Publication number
- EP3722434
- Application number
- EP19169121
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Apr 12, 2019
- Published
- Oct 14, 2020
- Granted
- Jul 27, 2022
- Protection ends at the latest
- Apr 11, 2039
- Next annual fee due
- Apr 30, 2027
- IPC classes
- C12N 15/86 (2006.01)
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- May 1, 2026
Change
Published in Swissreg on 01.05.2026
- Apr 30, 2026
Change
Published in Swissreg on 30.04.2026
- May 1, 2025
Change
Published in Swissreg on 01.05.2025
- May 1, 2024
Change
Published in Swissreg on 01.05.2024
- Jun 14, 2023
Transferred
- Owner
- Freeline Therapeutics Limited, Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX, United Kingdom → Ascend Gene and Cell Therapies Ltd, 3rd Floor 1 Ashley Road, Altrincham, Cheshire WA14 2DT, United Kingdom
Published in Swissreg on 14.06.2023
- May 10, 2023
Change
Published in Swissreg on 10.05.2023
- May 1, 2023
Change
Published in Swissreg on 01.05.2023
- Oct 7, 2022
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach, 8027 Zürich
Published in Swissreg on 07.10.2022
1 earlier entry
- Jul 27, 2022
Granted
Published in Swissreg on 27.07.2022
Parties
Inventor
82152 Planegg-Steinkirchen, DE
82152 Planegg-Steinkirchen, DE
82152 Planegg-Steinkirchen, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.